CONNECT WITH US
Tech

Tech

A startup called Warhound is genetically engineering dogs for the military

Engadget logo

Published on

Add as a preferred source on Google
A startup called Warhound is genetically engineering dogs for the military

Palmer Luckey’s Anduril will design protective body armor and other tools for them.

Warhound, a new startup that has just raised $200 million in funding, aims to genetically engineer war dogs for the US military and fit them with high-tech gear. It's a project by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey. Lamm has told Wired that Warhound has already started editing genes of the cell samples taken from its first batch of donor dogs. Specifically, the startup collected samples from top-performing military, police and first responder dog breeds in the US, mostly Belgian Malinois, some labradors and some shepherds. The goal is to clone them after scientists working for Colossal have tweaked their genes.

Those scientists will initially focus on making them less likely to develop health conditions that commonly affect their breeds, such as hip dysplasia and certain cancers. In the future, Lamm thinks the dogs could be enhanced further. Scientist could incorporate more genetic changes to make them faster and more agile or to enhance their sense of smell, Lamm told TechCrunch.

Luckey, if you'll recall, founded Oculus VR and designed the Oculus Rift headset. His company Anduril teamed up with OpenAI in 2024 to develop AI for the Pentagon . More recently, it secured a contract with the US Army to create its next-gen battlefield intelligence system alongside Palantir. Meanwhile, Lamm's biotech company is behind several "de-extinction" initiatives, including one that claims to have revived the dire wolf and another that aims to bring back the woolly mammoth .


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.